Analysts Offer Insights on Healthcare Companies: Herbalife (NYSE: HLF) and Icosavax (NASDAQ: ICVX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Herbalife (HLFResearch Report) and Icosavax (ICVXResearch Report) with bullish sentiments.

Herbalife (HLF)

Jefferies analyst Stephanie Wissink maintained a Buy rating on Herbalife yesterday and set a price target of $70.00. The company’s shares closed last Monday at $54.24.

According to TipRanks.com, Wissink is a 4-star analyst with an average return of 6.3% and a 56.0% success rate. Wissink covers the Consumer Goods sector, focusing on stocks such as Petco Health and Wellness Company, Bj’s Wholesale Club Holdings, and The Estée Lauder Companies.

Currently, the analyst consensus on Herbalife is a Moderate Buy with an average price target of $70.00.

See today’s analyst top recommended stocks >>

Icosavax (ICVX)

Jefferies analyst Kelechi Chikere maintained a Buy rating on Icosavax today and set a price target of $50.00. The company’s shares closed last Monday at $37.75.

According to TipRanks.com, Chikere is a 3-star analyst with an average return of 14.8% and a 70.0% success rate. Chikere covers the Healthcare sector, focusing on stocks such as Inovio Pharmaceuticals, Altimmune, and Vaxcyte.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Icosavax with a $50.00 average price target, representing a 29.3% upside. In a report issued on September 9, William Blair also reiterated a Buy rating on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.